ATRICURE INC (ATRC) Fundamental Analysis & Valuation

NASDAQ:ATRC • US04963C2098

Current stock price

29.845 USD
+0.31 (+1.05%)
At close:
29.845 USD
0 (0%)
After Hours:

This ATRC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ATRC Profitability Analysis

1.1 Basic Checks

  • ATRC had negative earnings in the past year.
  • In the past year ATRC had a positive cash flow from operations.
  • In the past 5 years ATRC reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ATRC reported negative operating cash flow in multiple years.
ATRC Yearly Net Income VS EBIT VS OCF VS FCFATRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • ATRC has a Return On Assets of -1.75%. This is in the better half of the industry: ATRC outperforms 70.11% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.33%, ATRC is in the better half of the industry, outperforming 70.65% of the companies in the same industry.
Industry RankSector Rank
ROA -1.75%
ROE -2.33%
ROIC N/A
ROA(3y)-4.68%
ROA(5y)-2.77%
ROE(3y)-6.18%
ROE(5y)-3.67%
ROIC(3y)N/A
ROIC(5y)N/A
ATRC Yearly ROA, ROE, ROICATRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • Looking at the Gross Margin, with a value of 74.98%, ATRC belongs to the top of the industry, outperforming 85.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
  • ATRC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.73%
ATRC Yearly Profit, Operating, Gross MarginsATRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

8

2. ATRC Health Analysis

2.1 Basic Checks

  • ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ATRC has been increased compared to 1 year ago.
  • Compared to 5 years ago, ATRC has more shares outstanding
  • The debt/assets ratio for ATRC has been reduced compared to a year ago.
ATRC Yearly Shares OutstandingATRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ATRC Yearly Total Debt VS Total AssetsATRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 5.77 indicates that ATRC is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.77, ATRC belongs to the best of the industry, outperforming 83.15% of the companies in the same industry.
  • ATRC has a debt to FCF ratio of 1.64. This is a very positive value and a sign of high solvency as it would only need 1.64 years to pay back of all of its debts.
  • ATRC has a Debt to FCF ratio of 1.64. This is amongst the best in the industry. ATRC outperforms 88.59% of its industry peers.
  • ATRC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • ATRC's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. ATRC outperforms 61.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.64
Altman-Z 5.77
ROIC/WACCN/A
WACC10.07%
ATRC Yearly LT Debt VS Equity VS FCFATRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.96 indicates that ATRC has no problem at all paying its short term obligations.
  • The Current ratio of ATRC (3.96) is better than 66.30% of its industry peers.
  • A Quick Ratio of 2.99 indicates that ATRC has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.99, ATRC is in the better half of the industry, outperforming 64.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 2.99
ATRC Yearly Current Assets VS Current LiabilitesATRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

6

3. ATRC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.43% over the past year.
  • Looking at the last year, ATRC shows a quite strong growth in Revenue. The Revenue has grown by 14.88% in the last year.
  • The Revenue has been growing by 20.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)81.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)14.88%
Revenue growth 3Y17.39%
Revenue growth 5Y20.95%
Sales Q2Q%13.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 59.24% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.06% on average over the next years. This is quite good.
EPS Next Y149.04%
EPS Next 2Y113.02%
EPS Next 3Y88.59%
EPS Next 5Y59.24%
Revenue Next Year13.05%
Revenue Next 2Y12.73%
Revenue Next 3Y12.82%
Revenue Next 5Y13.06%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ATRC Yearly Revenue VS EstimatesATRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ATRC Yearly EPS VS EstimatesATRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

3

4. ATRC Valuation Analysis

4.1 Price/Earnings Ratio

  • ATRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 468.16, which means the current valuation is very expensive for ATRC.
  • 62.50% of the companies in the same industry are more expensive than ATRC, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of ATRC to the average of the S&P500 Index (23.84), we can say ATRC is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 468.16
ATRC Price Earnings VS Forward Price EarningsATRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ATRC is valued a bit cheaper than the industry average as 63.59% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ATRC is valued a bit cheaper than 76.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.16
EV/EBITDA 123.86
ATRC Per share dataATRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ATRC's earnings are expected to grow with 88.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y113.02%
EPS Next 3Y88.59%

0

5. ATRC Dividend Analysis

5.1 Amount

  • No dividends for ATRC!.
Industry RankSector Rank
Dividend Yield 0%

ATRC Fundamentals: All Metrics, Ratios and Statistics

ATRICURE INC

NASDAQ:ATRC (3/13/2026, 8:10:35 PM)

After market: 29.845 0 (0%)

29.845

+0.31 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners100.89%
Inst Owner Change-1.54%
Ins Owners3.37%
Ins Owner Change9.62%
Market Cap1.49B
Revenue(TTM)534.53M
Net Income(TTM)-11.45M
Analysts81.33
Price Target52.31 (75.27%)
Short Float %7.18%
Short Ratio5.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.37%
Min EPS beat(2)91.46%
Max EPS beat(2)141.28%
EPS beat(4)4
Avg EPS beat(4)90.28%
Min EPS beat(4)40.06%
Max EPS beat(4)141.28%
EPS beat(8)7
Avg EPS beat(8)52.74%
EPS beat(12)11
Avg EPS beat(12)47.18%
EPS beat(16)12
Avg EPS beat(16)37.69%
Revenue beat(2)1
Avg Revenue beat(2)-0.58%
Min Revenue beat(2)-1.45%
Max Revenue beat(2)0.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)6
Avg Revenue beat(12)0.48%
Revenue beat(16)9
Avg Revenue beat(16)0.7%
PT rev (1m)-2.83%
PT rev (3m)-0.74%
EPS NQ rev (1m)35.08%
EPS NQ rev (3m)37.02%
EPS NY rev (1m)149.75%
EPS NY rev (3m)138.76%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 468.16
P/S 2.78
P/FCF 35.16
P/OCF 25.93
P/B 3.02
P/tB 7.11
EV/EBITDA 123.86
EPS(TTM)-0.13
EYN/A
EPS(NY)0.06
Fwd EY0.21%
FCF(TTM)0.85
FCFY2.84%
OCF(TTM)1.15
OCFY3.86%
SpS10.73
BVpS9.88
TBVpS4.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.75%
ROE -2.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.98%
FCFM 7.91%
ROA(3y)-4.68%
ROA(5y)-2.77%
ROE(3y)-6.18%
ROE(5y)-3.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.73%
F-Score7
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.64
Debt/EBITDA 6.12
Cap/Depr 73.3%
Cap/Sales 2.82%
Interest Coverage N/A
Cash Conversion 517.27%
Profit Quality N/A
Current Ratio 3.96
Quick Ratio 2.99
Altman-Z 5.77
F-Score7
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)160.68%
Cap/Depr(5y)143.92%
Cap/Sales(3y)6.13%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y149.04%
EPS Next 2Y113.02%
EPS Next 3Y88.59%
EPS Next 5Y59.24%
Revenue 1Y (TTM)14.88%
Revenue growth 3Y17.39%
Revenue growth 5Y20.95%
Sales Q2Q%13.05%
Revenue Next Year13.05%
Revenue Next 2Y12.73%
Revenue Next 3Y12.82%
Revenue Next 5Y13.06%
EBIT growth 1Y76.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year602.86%
EBIT Next 3Y111.53%
EBIT Next 5Y70.07%
FCF growth 1Y475.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y369.8%
OCF growth 3YN/A
OCF growth 5YN/A

ATRICURE INC / ATRC Fundamental Analysis FAQ

What is the fundamental rating for ATRC stock?

ChartMill assigns a fundamental rating of 5 / 10 to ATRC.


What is the valuation status for ATRC stock?

ChartMill assigns a valuation rating of 3 / 10 to ATRICURE INC (ATRC). This can be considered as Overvalued.


What is the profitability of ATRC stock?

ATRICURE INC (ATRC) has a profitability rating of 3 / 10.


What is the financial health of ATRICURE INC (ATRC) stock?

The financial health rating of ATRICURE INC (ATRC) is 8 / 10.